Gerhard Feil
Impact in
- Urology top 2%
- Urological Disorders and Treatments
- Developmental Biology top 5%
- Congenital limb and hand anomalies
Papers in ⓘ
- Co-authors
- Arnulf Stenzl (38 shared papers)K.-H. Bichler (7 shared papers)E. Petri (5 shared papers)Karl‐Dietrich Sievert (11 shared papers)Sabine Maurer (8 shared papers)Jörg Hennenlotter (7 shared papers)F. Majewski (2 shared papers)R. Seiler (2 shared papers)
- Journals
- The Journal of Urology (9 papers)European Journal of Pediatrics (3 papers)European Urology (3 papers)Der Urologe (9 papers)Molecular & Cellular Proteomics (1 paper)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Gerhard Feil
75 papers receiving 923 citations
Peers
Comparison fields: 5 of 89
- Urology 254
- Developmental Biology 64
- Surgery 513
- Biomaterials 130
- Cancer Research 94
Countries citing papers authored by Gerhard Feil
This map shows the geographic impact of Gerhard Feil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Feil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Feil more than expected).
Fields of papers citing papers by Gerhard Feil
This network shows the impact of papers produced by Gerhard Feil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Feil. The network helps show where Gerhard Feil may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerhard Feil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | [Polysyndactyly, short limbs, and genital malformations--a new syndrome?]. | 1971 | 68 |
| 2 | 2006 | 66 | |
| 3 | 1971 | 62 | |
| 4 | 2009 | 58 | |
| 5 | Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK). | 1999 | 55 |
| 6 | 2008 | 54 | |
| 7 | Renal cell carcinoma: relevance of angiogenetic factors. | 1999 | 51 |
| 8 | 2009 | 43 | |
| 9 | 1996 | 39 | |
| 10 | 2010 | 35 | |
| 11 | Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder. | 2003 | 34 |
| 12 | 2011 | 32 | |
| 13 | 2005 | 25 | |
| 14 | 2007 | 22 | |
| 15 | 2001 | 21 | |
| 16 | Renal cell carcinoma: immunohistological investigation of expression of the integrin alpha v beta 3. | 1999 | 21 |
| 17 | 2008 | 20 | |
| 18 | 2001 | 19 | |
| 19 | 2017 | 15 | |
| 20 | 2003 | 15 |
About Gerhard Feil
Gerhard Feil is a scholar working on Urology, Surgery, Biotechnology, Developmental Biology and Pulmonary and Respiratory Medicine, having authored 76 papers that have together received 962 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (28 papers), Tissue Engineering and Regenerative Medicine (20 papers), Urological Disorders and Treatments (16 papers), Urinary and Genital Oncology Studies (14 papers), Renal cell carcinoma treatment (7 papers), Epigenetics and DNA Methylation (6 papers), Cancer Research and Treatments (5 papers) and Electrospun Nanofibers in Biomedical Applications (5 papers). The work is most often cited by research in Urology (254 citations), Developmental Biology (64 citations), Surgery (513 citations), Biomaterials (130 citations) and Cancer Research (94 citations). Gerhard Feil has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Arnulf Stenzl, K.-H. Bichler, E. Petri, Karl‐Dietrich Sievert, Sabine Maurer, Jörg Hennenlotter, F. Majewski, R. Seiler, R. A. Pfeiffer and W. Lenz. Their work appears in journals such as The Journal of Urology, European Journal of Pediatrics, European Urology, Der Urologe and Molecular & Cellular Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.